Tallene Hacatoryan, Inc. – Trademark Portfolio
Entity Type: 03
Tallene Hacatoryan, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include THE CYSTERHOOD, PCOS WEIGHT LOSS, and A CYSTER & HER MISTER. The owner is based in Newport Beach, CA.
29 Saint Tropez
Newport Beach, CA 92660
Showing of trademarks Trademarks
Trademark Classifications
Tallene Hacatoryan, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Tallene Hacatoryan, Inc. have?
Tallene Hacatoryan, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Tallene Hacatoryan, Inc. file in?
Tallene Hacatoryan, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 9 (Computers & Electronics). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Tallene Hacatoryan, Inc.'s most well-known trademarks?
Tallene Hacatoryan, Inc.'s registered trademark portfolio includes well-known marks such as THE CYSTERHOOD, PCOS WEIGHT LOSS, and A CYSTER & HER MISTER. These are among 3 currently registered trademarks in the portfolio.
What is Tallene Hacatoryan, Inc.'s trademark registration success rate?
Tallene Hacatoryan, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.